{
  "spec_version": "4",
  "endpoint": "financials-segment",
  "stock_code": "4581",
  "company_name": "大正製薬ホールディングス",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/4581/current/#revenue-mix",
  "api_url": "/api/4581/financials/segment.json",
  "updated": "2026-09-20",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/4581/current/#revenue-mix",
  "source": {
    "segment": {
      "primary": [
        "有価証券報告書（セグメント情報）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
    },
    "region": {
      "primary": [
        "有価証券報告書（所在地別・海外売上高）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "地域区分は各期の開示区分をそのまま採録している"
    },
    "revenue_mix": {
      "primary": [
        "有価証券報告書（生産・受注及び販売の状況）"
      ],
      "extraction": "EDINET の XBRL と有価証券報告書の記述から機械抽出",
      "caveat": "軸（axis）は品目・用途・主要顧客など開示に依り、社ごと期ごとに揃わない。どの開示から起こした行かは source_tag 列を参照"
    }
  },
  "html_url": "https://the-shashi.com/tse/4581/current/#revenue-mix",
  "segment": [
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "セルフメディケーション事業",
      "sales": 180722,
      "profit": 28393,
      "assets": 302521
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬事業",
      "sales": 109413,
      "profit": 1755,
      "assets": 175302
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "セルフメディケーション事業",
      "sales": 179992,
      "profit": 30106,
      "assets": 319520
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬事業",
      "sales": 99781,
      "profit": 3352,
      "assets": 173423
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "セルフメディケーション事業",
      "sales": 183996,
      "profit": 30162,
      "assets": 337481
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬事業",
      "sales": 96096,
      "profit": 8207,
      "assets": 186314
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "セルフメディケーション事業",
      "sales": 180123,
      "profit": 30287,
      "assets": 355581
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬事業",
      "sales": 81428,
      "profit": 2685,
      "assets": 123321
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "セルフメディケーション事業",
      "sales": 220027,
      "profit": 18694,
      "assets": 510362
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬事業",
      "sales": 68500,
      "profit": 4144,
      "assets": 112319
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "セルフメディケーション事業",
      "sales": 226878,
      "profit": 19395,
      "assets": 521662
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬事業",
      "sales": 55101,
      "profit": 2495,
      "assets": 107499
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "セルフメディケーション事業",
      "sales": 229659,
      "profit": 14128,
      "assets": 549758
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬事業",
      "sales": 38543,
      "profit": -1319,
      "assets": 93281
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "セルフメディケーション事業",
      "sales": 263711,
      "profit": 29388,
      "assets": 573826
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬事業",
      "sales": 37669,
      "profit": -4513,
      "assets": 116673
    }
  ],
  "region": [
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 3102
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 26798
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 260234
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 2394
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 25134
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 252244
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 2584
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 28352
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 249156
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 2407
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 28571
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 230572
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 2470
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 43253
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "ヨーロッパ・アフリカ",
      "sales": 23776
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 219027
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 2414
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 42408
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "ヨーロッパ・アフリカ",
      "sales": 47784
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 189372
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 3672
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 49203
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "ヨーロッパ・アフリカ",
      "sales": 48682
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 166644
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 1183
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 64291
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "ヨーロッパ・アフリカ",
      "sales": 61227
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 174679
    }
  ],
  "revenue_mix": [
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "セルフメディケーション事業",
      "sales": 179992,
      "share_pct": null,
      "source_tag": "production_sales"
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "医薬事業",
      "sales": 99781,
      "share_pct": null,
      "source_tag": "production_sales"
    }
  ]
}